Shanghai Haoyuan Chemexpress Co (SHSE:688131) 3-Year Revenue Growth Rate : 25.70% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co 3-Year Revenue Growth Rate?

Shanghai Haoyuan Chemexpress Co's Revenue per Share for the three months ended in Mar. 2025 was ¥2.92.

During the past 12 months, Shanghai Haoyuan Chemexpress Co's average Revenue per Share Growth Rate was 20.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 25.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 30.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Shanghai Haoyuan Chemexpress Co was 64.60% per year. The lowest was -61.50% per year. And the median was 25.70% per year.

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Shanghai Haoyuan Chemexpress Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Shanghai Haoyuan Chemexpress Co (SHSE:688131) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Shanghai Haoyuan Chemexpress Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haoyuan Chemexpress Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.chemexpress.com.cn

Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.

Executives

Mei Kui

Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines